Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.

EVEREST MED (01952.HK) announced that, in relation to the exclusive licensing and collaboration agreement signed with Travere ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on July 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 41,600 ...

Food - Allergen - Peanut Distribution: British ColumbiaOntarioQuebec See the affected products and product photos for this ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Brookdale Senior Living Inc. reported today its occupancy for June 2026.Second Quarter and June 2026 Occupancy ...

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alector, Amgen, Beam, Chemomab, Everest, Fosun, GSK, LG, Niagen, Octave, OTR, Prime, Resmed, Scipher, ...

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug ​to treat patients with a ...

FDA grants accelerated approval to Vera's Trutakna for IgA nephropathy, first dual BAFF/APRIL inhibitor. Competes with ...

Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...

Golden Heaven Group Holdings, a Nasdaq-listed amusement park rental operator in China, announced unaudited financial results for the six months ended 31 March 2026, its fiscal first half.

SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...